Cerenome (NASDAQ: CNSY) surged 46.66% to $1.13 in Friday trading, with approximately 5.88 million shares changing hands—about nine times its average daily volume. The rally…
November 13, 2026
November 13, 2026
Rezolute’s Ersodetug Meets Phase 3 Tumor Hyperinsulinism Endpoint Ahead of 2027 FDA Discussions
Key Points Preliminary results show 13 of 16 participants achieved at least a 50% reduction in their glucose infusion rate, exceeding the nine responders required…
November 13, 2026
Annovis Secures Buntanetap Crystal-Form Patent Through 2044 Ahead of Phase 3 Alzheimer’s Readout
Key Points Annovis received a U.S. patent covering buntanetap Form B, the crystalline form used in its ongoing Alzheimer’s and Parkinson’s studies. The patent covers…
November 12, 2026
NervGen Wins FDA Breakthrough Therapy Designation for Spinal Cord Injury Drug as Phase 3 Enrollment Advances
Key Points NervGen received FDA Breakthrough Therapy designation for NVG-291 in chronic traumatic cervical motor-incomplete spinal cord injury. The decision followed FDA review of safety…
November 12, 2026
PRISM Mid-Day Movers: EV and Biotech are Today’s Leaders.
GreenPower Motor Company (NASDAQ: GP) exploded 194.51% to $1.32 in todays trading, reaching its session high as volume climbed to approximately 67.2 million shares—more than…
November 11, 2026
CareCloud Expands Wound Care Business With New Clients, EHR Integration and More Than $4 Million in Client Audit Appeals
Key Points CareCloud added multiple wound care clients in the fourth quarter and secured preferred-vendor status with Vantage Health Collective, initially supporting three practices. A…
November 11, 2026
PRISM Mid-Day Movers: Biotech and Fintech are Today’s Leaders.
SHF Holdings (NASDAQ: SHFS), which operates as Safe Harbor Financial, jumped 43.4% to $0.0228 today, with approximately 1.98 billion shares changing hands—nearly 30 times its…
November 11, 2026
NRx Pharma Begins Ketamine Sales Push, Targeting January 2027 Shipments and Margins Above 50%
Key Points NRx has launched commercial outreach for its U.S.-made, preservative-free ketamine, with initial supply agreements and preorders targeted for late 2026. Product shipments are…
November 09, 2026
Allogene’s Off-the-Shelf CAR T Shows Early Skin Score Gains in First Scleroderma Data
Allogene Therapeutics (NASDAQ: ALLO), a clinical-stage developer of off-the-shelf CAR T cell therapies, reported on November 9, 2026 the first clinical data from its Phase…
November 09, 2026
CorMedix to Acquire Heron’s Drug Portfolio, Targets Up to $60 Million in Annual Savings
Key Points CorMedix will acquire substantially all of Heron’s assets, including four commercial medicines, for cash, shares and potential future payments. Upfront consideration was valued…
Key Points Abeona acquired Ellodi Pharmaceuticals’ APT-1011, renamed ABO-801, for $20 million in common stock and potential future payments. The once-daily dissolving tablet is being…
Key Points LifeMD’s affiliated pharmacy can directly dispense and ship Lilly’s Zepbound and Foundayo to eligible patients nationwide. Patients can purchase prescribed medicines through LifeMD…